Basic Information
Basic information for UCA1-216-29aa
Peptide Name UCA1-216-29aa
Genome Position chr19:15831283-15831356,15834502-15834514[+]
Species Human
Peptide Sequence MLPDRLRSPLDHHRCRASGNSYGGGFPAI
Peptide Length 29
Unique No (UCA1-202-29aa,UCA1-204-29aa,UCA1-205-29aa,UCA1-208-29aa,UCA1-213-29aa,UCA1-214-29aa-2,UCA1-218-29aa,UCA1-220-29aa,UCA1-222-29aa,UCA1-223-29aa,UCA1-224-29aa,UCA1-226-29aa,UCA1-229-29aa,UCA1-233-29aa,UCA1-234-29aa,UCA1-235-29aa,UCA1-238-29aa,UCA1-240-29aa,UCA1-243-29aa,UCA1-244-29aa)
Grand Average of Hydropathicity -0.631
Relative Molecular Mass 3685.99
Experimental Evidences 3:lncORF,m6A,ribo
lncRNA ID/Name ENSG00000214049;UCA1
Transcript ID/Name ENST00000644567;UCA1-216
Transcript Length 2627
Coding Ability 0.3955
DNA Sequence Corresponding to Peptide ATGCTGCCCGATCGCCTCAGAAGCCCCTTGGACCATCACAGATGCCGAGCTTCGGGTAACTCTTACGGTGGAGGATTCCCAGCCATA
Experimental Evidences
   lncORF
   m6A
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :